HOME >> MEDICINE >> NEWS
Randomised Controlled Trial Of Aminosidine (Paromomycin) v Sodium Stibogluconate For Treating Visceral Leishmaniasis In North Bihar, India

(Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India)

Bihar in north east India accounts for half the annual worldwide cases of visceral leishmaniasis (a disease transmitted by sandfly bites). Dr P Olliaro of the World Health Organisation worked alongside a local medical team in Bihar to research the efficacy of the drug aminosidine and they report the findings of their study in this week's BMJ. The authors found it was significantly more effective (150 per cent) in producing a cure than the more traditional medication, sodium stibogluconate, to which the disease is becoming increasingly resistant. An additional advantage of aminosidine is that it lowers the overall burden to the health system, owing to the fact that the drug is cheaper than regular treatments and the shorter period of hospitalisation required.

Contact:

Dr P Olliaro, Manager, Steering Committee on Drugs for Malaria (CHEMAL), World Health Organisation, UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease, 20 Avenue Appia, Geneva, Switzerland olliarop@who.ch


'"/>

Contact: Jill Shepherd
jshepher@bma.org.uk
+44 171 383 6529
BMJ-British Medical Journal
17-Apr-1998


Page: 1

Related medicine news :

1. Controlled study after Dutch caf fire highlights teen mental-health problems after disasters
2. Controlled crying reduces infant sleep problems
3. Revolutionary New Procedure That Creates Controlled Heart Attack Performed For First Time In Southern California At Cedars-Sinai Medical Center
4. Promising Results For Woman-Controlled Anti-HIV Product
5. Randomized Placebo-Controlled Study On The Effects Of Oral Treatment With GinkgoBiloba Extract In Patients With Erectile Dysfunction
6. Trial reveals safer and simpler approach to treating children with cystic fibrosis
7. Trials launched to test treatment of cognitive dysfunction in schizophrenia
8. Randomisation phase of the DIRECT programme (DIabetic REtinopathy Candesartan Trials) completed
9. Trials on hormone therapy and hypertension treatment change practice, medication usage of patients
10. Trial results have dramatically reduced HRT use
11. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... October 08, 2019 , ... Cognosante has ... Department of Veterans Affairs Community Care Referrals and Authorizations program. The new task ... Health Share Referral Manager (HSRM), an enterprise-wide system used by community care staff ...
(Date:10/8/2019)... COLLEGE PARK, Md. (PRWEB) , ... October 08, ... ... to observe fungal infection progression in live samples, Meiqing Shi, associate professor with ... in the field. In his latest paper published in Nature Communications, Shi and ...
(Date:10/8/2019)... , ... October 08, 2019 , ... Over the past ... as a standout in the sports restaurant category by providing a higher-quality product and ... new fall menu as well as a "RAISE A MUG FOR THE CAUSE" campaign ...
(Date:10/8/2019)... ... 08, 2019 , ... METAvivor Research and Support Inc., a non-profit organization dedicated ... Stage IV Stampede campaign. The campaign will commence with two days of action and ... advocacy boot camp, a march, a Die-In (hosted by partner MET-UP), and visits with ...
(Date:10/8/2019)... FAYETTEVILLE, Ark. (PRWEB) , ... October 08, 2019 ... ... Hub has selected CardioWise, Inc. a Digital Health Awards 1st Round ... of UCSF Digital Health Awards was to select companies that promote faster, better, ...
Breaking Medicine News(10 mins):
(Date:10/19/2019)... Conn. (PRWEB) , ... October 19, 2019 , ... Hospital ... of 2019, according to new acquisition data from HealthCareMandA.com. The most recent quarter was ... Dollar volume was up sharply compared with the second quarter, totaling nearly $5.0 billion, ...
(Date:10/17/2019)... ... October 17, 2019 , ... Women’s concern in the wake of the ... implants is the subject of a September 24 article on CBS Miami. ... the Allergan recall has revived a number of issues, including a possible link between ...
(Date:10/15/2019)... ... October 14, 2019 , ... ... linearity and calibration verification kit, for Roche cobas® analyzers, Order No. 507ro. ... B (Apo-B). Each VALIDATE® LP2 kit, liquid, ready-to-use, and prepared using ...
Breaking Medicine Technology:
Cached News: